- Home
- CVKD vs ICCT Comparison
CVKD vs ICCT Comparison
Compare CVKD & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ICCT
- Stock Information
- Founded
- CVKD 2022
- ICCT 1992
- Country
- CVKD United States
- ICCT United States
- Employees
- CVKD N/A
- ICCT N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ICCT Computer Software: Prepackaged Software
- Sector
- CVKD Health Care
- ICCT Technology
- Exchange
- CVKD Nasdaq
- ICCT Nasdaq
- Market Cap
- CVKD 17.1M
- ICCT 5.2M
- IPO Year
- CVKD 2023
- ICCT N/A
- Fundamental
- Price
- CVKD $15.24
- ICCT $0.28
- Analyst Decision
- CVKD Strong Buy
- ICCT
- Analyst Count
- CVKD 2
- ICCT 0
- Target Price
- CVKD $52.50
- ICCT N/A
- AVG Volume (30 Days)
- CVKD 59.6K
- ICCT 5.8M
- Earning Date
- CVKD 11-08-2024
- ICCT 11-18-2024
- Dividend Yield
- CVKD N/A
- ICCT N/A
- EPS Growth
- CVKD N/A
- ICCT N/A
- EPS
- CVKD N/A
- ICCT N/A
- Revenue
- CVKD N/A
- ICCT $10,266,331.00
- Revenue This Year
- CVKD N/A
- ICCT N/A
- Revenue Next Year
- CVKD N/A
- ICCT N/A
- P/E Ratio
- CVKD N/A
- ICCT N/A
- Revenue Growth
- CVKD N/A
- ICCT 34.56
- 52 Week Low
- CVKD $5.40
- ICCT $0.25
- 52 Week High
- CVKD $32.55
- ICCT $3.20
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- ICCT 35.30
- Support Level
- CVKD $11.19
- ICCT $0.34
- Resistance Level
- CVKD $15.93
- ICCT $0.37
- Average True Range (ATR)
- CVKD 1.36
- ICCT 0.07
- MACD
- CVKD 0.23
- ICCT -0.00
- Stochastic Oscillator
- CVKD 61.01
- ICCT 5.67
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.